Click for best price
Inactivated Porcine Parvovirus Vaccine Market Size, Share 2023
The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Parvovirus Vaccine. This report contains market size and forecasts of Inactivated Porcine Parvovirus Vaccine in global, including the following market information:
Global Inactivated Porcine Parvovirus Vaccine Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Inactivated Porcine Parvovirus Vaccine Market Sales, 2018-2023, 2024-2032, (M Doses)
Global top five Inactivated Porcine Parvovirus Vaccine companies in 2022 (%)
The global Inactivated Porcine Parvovirus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
<107.0 TCID50/mL Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inactivated Porcine Parvovirus Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inactivated Porcine Parvovirus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Porcine Parvovirus Vaccine Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, by Type, 2022 (%)
<107.0 TCID50/mL
?107.0 TCID50/mL
Global Inactivated Porcine Parvovirus Vaccine Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, by Application, 2022 (%)
Sows
Gilts
Boars
Global Inactivated Porcine Parvovirus Vaccine Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inactivated Porcine Parvovirus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inactivated Porcine Parvovirus Vaccine revenues share in global market, 2022 (%)
Key companies Inactivated Porcine Parvovirus Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Inactivated Porcine Parvovirus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inactivated Porcine Parvovirus Vaccine, market overview.
Chapter 2: Global Inactivated Porcine Parvovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inactivated Porcine Parvovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Inactivated Porcine Parvovirus Vaccine Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Inactivated Porcine Parvovirus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Porcine Parvovirus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Porcine Parvovirus Vaccine Overall Market Size
2.1 Global Inactivated Porcine Parvovirus Vaccine Market Size: 2022 VS 2032
2.2 Global Inactivated Porcine Parvovirus Vaccine Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Inactivated Porcine Parvovirus Vaccine Sales: 2018-2032
3 Company Landscape
3.1 Top Inactivated Porcine Parvovirus Vaccine Players in Global Market
3.2 Top Global Inactivated Porcine Parvovirus Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Porcine Parvovirus Vaccine Revenue by Companies
3.4 Global Inactivated Porcine Parvovirus Vaccine Sales by Companies
3.5 Global Inactivated Porcine Parvovirus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inactivated Porcine Parvovirus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inactivated Porcine Parvovirus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Porcine Parvovirus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Porcine Parvovirus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Porcine Parvovirus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Porcine Parvovirus Vaccine Market Size Markets, 2022 & 2032
4.1.2 <107.0 TCID50/mL
4.1.3 ?107.0 TCID50/mL
4.2 By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2024-2032
4.2.3 By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
4.3 By Type - Global Inactivated Porcine Parvovirus Vaccine Sales & Forecasts
4.3.1 By Type - Global Inactivated Porcine Parvovirus Vaccine Sales, 2018-2023
4.3.2 By Type - Global Inactivated Porcine Parvovirus Vaccine Sales, 2024-2032
4.3.3 By Type - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
4.4 By Type - Global Inactivated Porcine Parvovirus Vaccine Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Porcine Parvovirus Vaccine Market Size, 2022 & 2032
5.1.2 Sows
5.1.3 Gilts
5.1.4 Boars
5.2 By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2024-2032
5.2.3 By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
5.3 By Application - Global Inactivated Porcine Parvovirus Vaccine Sales & Forecasts
5.3.1 By Application - Global Inactivated Porcine Parvovirus Vaccine Sales, 2018-2023
5.3.2 By Application - Global Inactivated Porcine Parvovirus Vaccine Sales, 2024-2032
5.3.3 By Application - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
5.4 By Application - Global Inactivated Porcine Parvovirus Vaccine Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Inactivated Porcine Parvovirus Vaccine Market Size, 2022 & 2032
6.2 By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue, 2024-2032
6.2.3 By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
6.3 By Region - Global Inactivated Porcine Parvovirus Vaccine Sales & Forecasts
6.3.1 By Region - Global Inactivated Porcine Parvovirus Vaccine Sales, 2018-2023
6.3.2 By Region - Global Inactivated Porcine Parvovirus Vaccine Sales, 2024-2032
6.3.3 By Region - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032
6.4.2 By Country - North America Inactivated Porcine Parvovirus Vaccine Sales, 2018-2032
6.4.3 US Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.4.4 Canada Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.4.5 Mexico Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032
6.5.2 By Country - Europe Inactivated Porcine Parvovirus Vaccine Sales, 2018-2032
6.5.3 Germany Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.4 France Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.5 U.K. Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.6 Italy Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.7 Russia Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.8 Nordic Countries Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.5.9 Benelux Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032
6.6.2 By Region - Asia Inactivated Porcine Parvovirus Vaccine Sales, 2018-2032
6.6.3 China Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.6.4 Japan Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.6.5 South Korea Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.6.6 Southeast Asia Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.6.7 India Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032
6.7.2 By Country - South America Inactivated Porcine Parvovirus Vaccine Sales, 2018-2032
6.7.3 Brazil Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.7.4 Argentina Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Sales, 2018-2032
6.8.3 Turkey Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.8.4 Israel Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.8.5 Saudi Arabia Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
6.8.6 UAE Inactivated Porcine Parvovirus Vaccine Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Merck Animal Health
7.1.1 Merck Animal Health Company Summary
7.1.2 Merck Animal Health Business Overview
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.1.4 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Animal Health Key News & Latest Developments
7.2 HIPRA
7.2.1 HIPRA Company Summary
7.2.2 HIPRA Business Overview
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.2.4 HIPRA Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 HIPRA Key News & Latest Developments
7.3 Zoetis
7.3.1 Zoetis Company Summary
7.3.2 Zoetis Business Overview
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.3.4 Zoetis Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zoetis Key News & Latest Developments
7.4 Ceva
7.4.1 Ceva Company Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.4.4 Ceva Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Key News & Latest Developments
7.5 Bioveta
7.5.1 Bioveta Company Summary
7.5.2 Bioveta Business Overview
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.5.4 Bioveta Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Bioveta Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.6.4 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Company Summary
7.7.2 Harbin Pharmaceutical Group Business Overview
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.7.4 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Company Summary
7.8.2 Wuhan Keqian Biology Business Overview
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.8.4 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Wuhan Keqian Biology Key News & Latest Developments
7.9 DHN
7.9.1 DHN Company Summary
7.9.2 DHN Business Overview
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.9.4 DHN Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 DHN Key News & Latest Developments
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Company Summary
7.10.2 China Animal Husbandy Industry Business Overview
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.10.4 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 China Animal Husbandy Industry Key News & Latest Developments
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Company Summary
7.11.2 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Business Overview
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.11.4 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Qilu Animal Health Products Factorys Key News & Latest Developments
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Company Summary
7.12.2 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Business Overview
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.12.4 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Shandong HuaHong Biological Engineering Key News & Latest Developments
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Company Summary
7.13.2 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Business Overview
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.13.4 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Shanghai Hile Biological Key News & Latest Developments
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Company Summary
7.14.2 Liaoning Yikang Biological Business Overview
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.14.4 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Liaoning Yikang Biological Key News & Latest Developments
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Company Summary
7.15.2 Jilin Zhengye Biological Product Business Overview
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Major Product Offerings
7.15.4 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Jilin Zhengye Biological Product Key News & Latest Developments
8 Global Inactivated Porcine Parvovirus Vaccine Production Capacity, Analysis
8.1 Global Inactivated Porcine Parvovirus Vaccine Production Capacity, 2018-2032
8.2 Inactivated Porcine Parvovirus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Porcine Parvovirus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Porcine Parvovirus Vaccine Supply Chain Analysis
10.1 Inactivated Porcine Parvovirus Vaccine Industry Value Chain
10.2 Inactivated Porcine Parvovirus Vaccine Upstream Market
10.3 Inactivated Porcine Parvovirus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Porcine Parvovirus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Inactivated Porcine Parvovirus Vaccine in Global Market
Table 2. Top Inactivated Porcine Parvovirus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inactivated Porcine Parvovirus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inactivated Porcine Parvovirus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Inactivated Porcine Parvovirus Vaccine Sales by Companies, (M Doses), 2018-2023
Table 6. Global Inactivated Porcine Parvovirus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inactivated Porcine Parvovirus Vaccine Price (2018-2023) & (US$/K Doses)
Table 8. Global Manufacturers Inactivated Porcine Parvovirus Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Porcine Parvovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Porcine Parvovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2018-2023
Table 15. By Type - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2024-2032
Table 16. By Application ? Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2018-2023
Table 20. By Application - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2024-2032
Table 21. By Region ? Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2018-2023
Table 25. By Region - Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), 2024-2032
Table 26. By Country - North America Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2018-2023
Table 29. By Country - North America Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2024-2032
Table 30. By Country - Europe Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2024-2032
Table 34. By Region - Asia Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2024-2032
Table 38. By Country - South America Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2018-2023
Table 41. By Country - South America Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2024-2032
Table 42. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Sales, (M Doses), 2024-2032
Table 46. Merck Animal Health Company Summary
Table 47. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 48. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 49. Merck Animal Health Key News & Latest Developments
Table 50. HIPRA Company Summary
Table 51. HIPRA Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 52. HIPRA Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 53. HIPRA Key News & Latest Developments
Table 54. Zoetis Company Summary
Table 55. Zoetis Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 56. Zoetis Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 57. Zoetis Key News & Latest Developments
Table 58. Ceva Company Summary
Table 59. Ceva Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 60. Ceva Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 61. Ceva Key News & Latest Developments
Table 62. Bioveta Company Summary
Table 63. Bioveta Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 64. Bioveta Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 65. Bioveta Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 68. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Harbin Pharmaceutical Group Company Summary
Table 71. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 72. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 73. Harbin Pharmaceutical Group Key News & Latest Developments
Table 74. Wuhan Keqian Biology Company Summary
Table 75. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 76. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 77. Wuhan Keqian Biology Key News & Latest Developments
Table 78. DHN Company Summary
Table 79. DHN Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 80. DHN Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 81. DHN Key News & Latest Developments
Table 82. China Animal Husbandy Industry Company Summary
Table 83. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 84. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 85. China Animal Husbandy Industry Key News & Latest Developments
Table 86. Qilu Animal Health Products Factorys Company Summary
Table 87. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 88. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 89. Qilu Animal Health Products Factorys Key News & Latest Developments
Table 90. Shandong HuaHong Biological Engineering Company Summary
Table 91. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 92. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 93. Shandong HuaHong Biological Engineering Key News & Latest Developments
Table 94. Shanghai Hile Biological Company Summary
Table 95. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 96. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 97. Shanghai Hile Biological Key News & Latest Developments
Table 98. Liaoning Yikang Biological Company Summary
Table 99. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 100. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 101. Liaoning Yikang Biological Key News & Latest Developments
Table 102. Jilin Zhengye Biological Product Company Summary
Table 103. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product Offerings
Table 104. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2018-2023)
Table 105. Jilin Zhengye Biological Product Key News & Latest Developments
Table 106. Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 107. Global Inactivated Porcine Parvovirus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Inactivated Porcine Parvovirus Vaccine Production by Region, 2018-2023 (M Doses)
Table 109. Global Inactivated Porcine Parvovirus Vaccine Production by Region, 2024-2032 (M Doses)
Table 110. Inactivated Porcine Parvovirus Vaccine Market Opportunities & Trends in Global Market
Table 111. Inactivated Porcine Parvovirus Vaccine Market Drivers in Global Market
Table 112. Inactivated Porcine Parvovirus Vaccine Market Restraints in Global Market
Table 113. Inactivated Porcine Parvovirus Vaccine Raw Materials
Table 114. Inactivated Porcine Parvovirus Vaccine Raw Materials Suppliers in Global Market
Table 115. Typical Inactivated Porcine Parvovirus Vaccine Downstream
Table 116. Inactivated Porcine Parvovirus Vaccine Downstream Clients in Global Market
Table 117. Inactivated Porcine Parvovirus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Porcine Parvovirus Vaccine Segment by Type in 2022
Figure 2. Inactivated Porcine Parvovirus Vaccine Segment by Application in 2022
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inactivated Porcine Parvovirus Vaccine Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Inactivated Porcine Parvovirus Vaccine Revenue, 2018-2032 (US$, Mn)
Figure 7. Inactivated Porcine Parvovirus Vaccine Sales in Global Market: 2018-2032 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2022
Figure 9. By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 11. By Type - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 12. By Type - Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses), 2018-2032
Figure 13. By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 15. By Application - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 16. By Application - Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses), 2018-2032
Figure 17. By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 20. By Region - Global Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 21. By Country - North America Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 22. By Country - North America Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 23. US Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 28. Germany Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 29. France Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 37. China Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 41. India Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 43. By Country - South America Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 44. Brazil Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share, 2018-2032
Figure 48. Turkey Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Inactivated Porcine Parvovirus Vaccine Revenue, (US$, Mn), 2018-2032
Figure 52. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses), 2018-2032
Figure 53. The Percentage of Production Inactivated Porcine Parvovirus Vaccine by Region, 2022 VS 2032
Figure 54. Inactivated Porcine Parvovirus Vaccine Industry Value Chain
Figure 55. Marketing Channels
